Aclysiran, an RNAi therapeutic agent targeting ACLY, treats hypercholesterolemia and atherosclerosis in ApoE–/– mice - Chen, Meijie; Little, Peter J.; Kong, Sudong; Banach, Maciej; Weng, Jianping; Xu, Suowen (Acta pharmaceutica Sinica. B, 2024)